Print PDF

Sheppard Mullin Represents Provepharm Life Solutions in Acquisition of Apollo Pharmaceuticals USA

12.03.2020

Sheppard Mullin represented French-based pharmaceutical company, Provepharm Life Solutions, in its acquisition of Florida-based Apollo Pharmaceuticals USA Inc., which specializes in the commercialization of sterile injectable products for hospital use. Provepharm's strategic purchase enables it to strengthen its position in the US market, particularly through the expansion of its product range, initially by integrating Apollo’s four registered products.

The Sheppard Mullin deal team was led by partner Luca Salvi and included special counsel Cedric Powell and Malika Levarlet and associate Karl Buhler.  Other members of the team included, among others, Allison Fulton on FDA matters; Keith Gercken and John Crisp on tax matters; Claudia Hinsch on employee benefits matters; Sean Kirby on labor matters; and Carlo Van den Bosch on IP matters.

Click here to read the press release.

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.